Skip to main content

NATCO 15 (Lansoprazole Delayed-Release 15 mg)

Pill with imprint NATCO 15 is Green & Pink, Capsule-shape and has been identified as Lansoprazole Delayed-Release 15 mg. It is supplied by Breckenridge Pharmaceutical, Inc.

Lansoprazole is used in the treatment of barrett's esophagus; duodenal ulcer; duodenal ulcer prophylaxis; gerd; erosive esophagitis and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Lansoprazole 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for NATCO 15

Lansoprazole Delayed-Release

Imprint
NATCO 15
Strength
15 mg
Color
Green & Pink
Shape
Capsule-shape
Availability
Rx and/or OTC
Drug Class
Proton pump inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Breckenridge Pharmaceutical, Inc.
Inactive Ingredients
acetone, isopropyl alcohol, magnesium carbonate, methacrylic acid - ethyl acrylate copolymer (1:1) type a, polyethylene glycol 4000, polysorbate 80, sucrose, corn starch, magnesium silicate, titanium dioxide, D&C Red No. 28, FD&C Blue No. 1, FD&C Green No. 3, FD&C Red No. 40, water, ammonia, potassium hydroxide, propylene glycol, shellac

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
51991-0771 (Discontinued) Breckenridge Pharmaceutical, Inc.
45963-0460 (Discontinued) Actavis Pharma, Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.